Today, pancreatic cancer remains one of the most lethal malignancies facing the global population. The 5-year survival rate for patients with pancreatic ductal adenocarcinoma (PDAC) is only about 3%, and PDAC isRead More…

Tumor-associated inflammation (TAI) is an important hallmark of all cancers and involves all cells in the tumor microenvironment (TME), which describes the entire spectrum of cancer cells, immune cells, endothelial cells, andRead More…